News

AI & technology

→

How eCOA/ePRO is transforming clinical trials

How eCOA/ePRO is transforming clinical trials

25-Nov-2024

Helen Harrington’s journey: Patience, passion, and problem-solving

Helen Harrington’s journey: Patience, passion, and problem-solving

20-Nov-2024

By Liza Laws

Tran Pham: Breaking barriers and building biopharma solutions

Tran Pham: Breaking barriers and building biopharma solutions

20-Nov-2024

By Liza Laws

C Ray Therapeutics raises $100 million to develop radiopharmaceuticals

C Ray Therapeutics raises $100 million to develop radiopharmaceuticals

19-Nov-2024

By Clara Rodriguez Fernandez

Promotional features

→

Streamlining early phase drug development with continuous flow technologies

Streamlining early phase drug development with continuous flow technologies

Paid for and in partnership with Lonza Small Molecules

Achieving data integrity: Best practices for secure and reliable data management

Achieving data integrity: Best practices for secure and reliable data management

Paid for and content provided by METTLER TOLEDO

AI transforms route scouting for faster drug synthesis

AI transforms route scouting for faster drug synthesis

Paid for and in partnership with Lonza Small Molecules

Decentralized clinical trials: The trends, the market and the future

Decentralized clinical trials: The trends, the market and the future

Paid for and content provided by DHL Supply Chain

APIs

→

FDA grants orphan drug designation to CervoMed’s dementia drug

FDA grants orphan drug designation to CervoMed’s dementia drug

28-Nov-2024

AstraZeneca claims phase 3 success with combination therapy for prostate cancer

AstraZeneca claims phase 3 success with combination therapy for prostate cancer

26-Nov-2024

By Clara Rodriguez Fernandez

Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease

Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease

19-Nov-2024

By Larissa Warneck-Silvestrin

Tirzepatide prevents type 2 diabetes in 99% of prediabetic patients for 3 years

Tirzepatide prevents type 2 diabetes in 99% of prediabetic patients for 3 years

14-Nov-2024

By Clara Rodriguez Fernandez

Contract manufacturing & logistics

→

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

15-Nov-2024

By Liza Laws

AstraZeneca doubles down on US manufacturing with $3.5 billion investment

AstraZeneca doubles down on US manufacturing with $3.5 billion investment

14-Nov-2024

By Jonathan Smith

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Drug delivery & innovation

→

Brixton Biosciences: Drug-free pain relief for knee osteoarthritis

Brixton Biosciences: Drug-free pain relief for knee osteoarthritis

22-Nov-2024

Overcoming nonspecific binding challenges in pharmacokinetic assays

Overcoming nonspecific binding challenges in pharmacokinetic assays

14-Nov-2024

By Liza Laws

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

08-Nov-2024

By Liza Laws

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

07-Nov-2024

By Clara Rodriguez Fernandez

Ingredients

→

Abbisko’s pimicotinib hits primary endpoint in phase 3 TGCT trial

Abbisko’s pimicotinib hits primary endpoint in phase 3 TGCT trial

12-Nov-2024

By Jonathan Smith

FDA grants accelerated approval to Novartis’ Scemblix as a first-line leukemia therapy

FDA grants accelerated approval to Novartis’ Scemblix as a first-line leukemia therapy

05-Nov-2024

By Clara Rodriguez Fernandez

GSK beefs up US manufacturing site with $800 million investment

GSK beefs up US manufacturing site with $800 million investment

29-Oct-2024

By Jonathan Smith

Markets & regulatory news

→

Adragos Pharma snaps up Baccinex to expand CDMO network

Adragos Pharma snaps up Baccinex to expand CDMO network

26-Nov-2024

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

Genesis Therapeutics partners with NVIDIA to boost AI-driven drug discovery

15-Nov-2024

By Liza Laws

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Mergers & deals

→

Mitsubishi teams up with Dewpoint in $480m ALS deal

Mitsubishi teams up with Dewpoint in $480m ALS deal

05-Dec-2024

By Jonathan Smith

Top 5 radiopharmaceuticals startups with VC backing

Top 5 radiopharmaceuticals startups with VC backing

05-Dec-2024

By Clara Rodriguez Fernandez

Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox

Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox

03-Dec-2024

Clinical trials & development

→

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug

21-Nov-2024

By Helen Albert

US companies enhancing decentralized clinical trials

US companies enhancing decentralized clinical trials

13-Nov-2024

By Larissa Warneck-Silvestrin

Medable and Google Cloud partner to deliver digital clinical trials technology

Medable and Google Cloud partner to deliver digital clinical trials technology

13-Nov-2024

By Clara Rodriguez Fernandez

Transparency and remote options key in clinical trial engagement

Transparency and remote options key in clinical trial engagement

13-Nov-2024

By Liza Laws